Proto Labs, Inc.
PRLB
$38.72
-$0.60-1.53%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 126.21M | 121.75M | 125.62M | 125.63M | 127.89M |
| Total Other Revenue | -- | -- | -- | -- | 160.00K |
| Total Revenue | 126.21M | 121.75M | 125.62M | 125.63M | 127.89M |
| Cost of Revenue | 70.51M | 69.79M | 68.39M | 69.09M | 70.42M |
| Gross Profit | 55.70M | 51.96M | 57.23M | 56.55M | 57.47M |
| SG&A Expenses | 40.60M | 38.17M | 38.88M | 39.89M | 39.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 121.71M | 117.66M | 117.04M | 119.63M | 121.06M |
| Operating Income | 4.49M | 4.09M | 8.58M | 6.00M | 6.83M |
| Income Before Tax | 5.99M | -282.00K | 9.87M | 7.36M | 7.73M |
| Income Tax Expenses | 2.39M | 122.00K | 2.68M | 2.82M | 2.46M |
| Earnings from Continuing Operations | 3.60M | -404.00K | 7.19M | 4.54M | 5.27M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.60M | -404.00K | 7.19M | 4.54M | 5.27M |
| EBIT | 4.49M | 4.09M | 8.58M | 6.00M | 6.83M |
| EBITDA | 13.19M | 13.24M | 17.49M | 14.97M | 15.93M |
| EPS Basic | 0.15 | -0.02 | 0.29 | 0.18 | 0.21 |
| Normalized Basic EPS | 0.15 | 0.14 | 0.25 | 0.18 | 0.19 |
| EPS Diluted | 0.15 | -0.02 | 0.29 | 0.18 | 0.20 |
| Normalized Diluted EPS | 0.15 | 0.14 | 0.25 | 0.18 | 0.19 |
| Average Basic Shares Outstanding | 24.14M | 24.47M | 24.98M | 25.31M | 25.62M |
| Average Diluted Shares Outstanding | 24.44M | 24.47M | 25.02M | 25.37M | 25.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |